HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Luo Selected Research

4-vinylguaiacol

2/20214-Vinylguaiacol, an Active Metabolite of Ferulic Acid by Enteric Microbiota and Probiotics, Possesses Significant Activities against Drug-Resistant Human Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Luo Research Topics

Disease

43Neoplasms (Cancer)
01/2024 - 10/2011
22Prostatic Neoplasms (Prostate Cancer)
11/2023 - 10/2010
18Ischemic Stroke
12/2023 - 05/2012
16Inflammation (Inflammations)
01/2024 - 04/2015
14Stroke (Strokes)
04/2024 - 09/2009
13Atherosclerosis
09/2023 - 11/2011
10Infections
04/2024 - 12/2018
9Reperfusion Injury
03/2024 - 09/2009
9Hypoxia (Hypoxemia)
02/2024 - 04/2005
8Pain (Aches)
01/2024 - 01/2016
7Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 02/2017
7Neoplasm Metastasis (Metastasis)
02/2023 - 10/2008
6Diabetic Retinopathy (Retinopathy, Diabetic)
01/2024 - 06/2019
6Body Weight (Weight, Body)
09/2023 - 12/2012
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 01/2012
5Brain Ischemia (Cerebral Ischemia)
03/2024 - 10/2008
5Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 07/2015
5Diabetes Mellitus
05/2021 - 08/2014
5Atherosclerotic Plaque (Atheroma)
05/2021 - 01/2015
5Hepatocellular Carcinoma (Hepatoma)
09/2020 - 01/2019
5Liver Neoplasms (Liver Cancer)
01/2020 - 01/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 01/2015
4Colonic Neoplasms (Colon Cancer)
04/2024 - 02/2021
4Hemorrhage
04/2024 - 08/2021
4Type 2 Diabetes Mellitus (MODY)
03/2024 - 04/2016
4Obesity
09/2023 - 01/2022
4Ischemia
02/2023 - 12/2016
4Rectal Neoplasms (Rectal Cancer)
01/2023 - 07/2020
4Rheumatoid Arthritis
11/2022 - 01/2019
4Fibrosis (Cirrhosis)
01/2021 - 09/2005
4Cardiotoxicity
01/2017 - 01/2013
3COVID-19
04/2024 - 01/2020
3Pathologic Constriction (Stenosis)
04/2024 - 01/2007
3Hyperlipidemias (Hyperlipidemia)
03/2024 - 05/2021
3Blindness (Hysterical Blindness)
01/2024 - 01/2022
3Carcinogenesis
12/2023 - 09/2015
3Non-alcoholic Fatty Liver Disease
02/2023 - 04/2015
3Myocardial Infarction
01/2023 - 11/2011
3Pneumonia (Pneumonitis)
12/2022 - 01/2020
3Esophageal Squamous Cell Carcinoma
12/2022 - 01/2021
3Vascular Diseases (Vascular Disease)
01/2022 - 07/2012
3Infarction (Infarctions)
06/2018 - 01/2012
3Alzheimer Disease (Alzheimer's Disease)
01/2016 - 04/2009
3Hypertension (High Blood Pressure)
11/2014 - 04/2012
3Fecal Incontinence
01/2005 - 01/2004
2Thrombosis (Thrombus)
04/2024 - 02/2023

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2002
10oxidized low density lipoproteinIBA
09/2023 - 01/2015
10LipidsIBA
02/2023 - 08/2013
9Biomarkers (Surrogate Marker)IBA
12/2022 - 07/2012
7Therapeutic UsesIBA
12/2023 - 10/2011
6Apolipoproteins E (ApoE)IBA
05/2021 - 08/2013
5RNA (Ribonucleic Acid)IBA
12/2023 - 01/2019
5Blood Glucose (Blood Sugar)IBA
09/2023 - 08/2014
5Hormones (Hormone)IBA
01/2015 - 10/2010
4notoginsenoside R1IBA
03/2024 - 02/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024 - 04/2005
4InflammasomesIBA
01/2024 - 02/2018
4TeaIBA
09/2023 - 01/2017
4Oxygen (Dioxygen)IBA
01/2023 - 09/2009
4C-Reactive ProteinIBA
01/2023 - 01/2007
4Retinaldehyde (Retinal)IBA
11/2022 - 06/2019
4FlavonoidsIBA
05/2022 - 01/2017
4CholesterolIBA
03/2022 - 03/2017
4Caspase 3 (Caspase-3)IBA
03/2019 - 01/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 02/2008
3Sirtuin 1IBA
12/2023 - 03/2019
3TabletsIBA
12/2023 - 04/2017
3CytokinesIBA
12/2022 - 12/2014
3AntibodiesIBA
07/2022 - 10/2011
3Triglycerides (Triacylglycerol)IBA
03/2022 - 03/2017
3ChemokinesIBA
01/2022 - 04/2019
3Peptides (Polypeptides)IBA
01/2022 - 10/2008
3Indicators and Reagents (Reagents)IBA
01/2021 - 05/2006
3AntigensIBA
01/2021 - 10/2011
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2009
3Phosphotransferases (Kinase)IBA
10/2020 - 04/2015
3BilirubinIBA
09/2020 - 05/2012
3HDL CholesterolIBA
09/2020 - 11/2014
3SolutionsIBA
06/2020 - 01/2012
3AndrogensIBA
01/2020 - 10/2010
3EnzymesIBA
10/2019 - 02/2008
3Transcription Factors (Transcription Factor)IBA
02/2018 - 06/2014
3Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 01/2013
2Circular RNAIBA
04/2024 - 01/2021
2SaponinsIBA
03/2024 - 11/2018
2Cyclin AIBA
01/2024 - 01/2021
2artemisinin (artemisinine)IBA
01/2024 - 04/2022
2artenimol (dihydroartemisinin)IBA
01/2024 - 04/2022

Therapy/Procedure

25Therapeutics
03/2024 - 09/2009
7Drug Therapy (Chemotherapy)
01/2023 - 01/2012
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 11/2017
6Prostatectomy (Retropubic Prostatectomy)
04/2023 - 05/2013
5Neoadjuvant Therapy
05/2024 - 01/2021
4Moxibustion
11/2022 - 01/2019
4Aftercare (After-Treatment)
01/2021 - 10/2014
3Hematopoietic Stem Cell Transplantation
08/2023 - 01/2016
3Chemoprevention
04/2022 - 02/2018
3Nephrectomy
11/2021 - 04/2011
3Transplantation
11/2017 - 09/2005